Pancreas / Islet Cell Transplant Clinical Trials
Islet Transplantation in Type 1 Diabetes
This study is to determine the safety and effectiveness of islet transplantation, combined with immunosuppressive medications, for treating type 1 diabetes in individuals experiencing hypoglycemia unawareness and severe hypoglycemic episode. Learn more . . .
Single-Center, Open-Label Clinical Trial of the Efficacy of Peritransplant Administration of Deoxyspergualin in Promoting Restoration of Insulin Independence after Single-Donor Islet Cell Allotransplantation in Non-Uremic Type 1 Diabetic Recipients (CIT 03)
This study will assess the safety and efficacy of deoxyspergualin (DSG), an immunosuppressant drug, on post-transplant islet function in people with type 1 diabetes who have not responded to intensive insulin therapy. Learn more . . .
Islet Transplantation versus Intensive Insulin Therapy in Type 1 Diabetic Kidney Allograft Recipients (CIT 06)
The purpose of this study is to compare the safety and effectiveness of islet transplantation versus intensive insulin treatment (ITT) for treating type 1 diabetes in patients who have received kidney transplants. Learn more . . .
A Pilot Study of Islet Transplantation in Non-Uremic Diabetic Patients
The purpose of this study is to evaluate the safety and effectiveness of islet transplantation utilizing the Edmonton Protocol immunosuppressive regime. Learn more . . .
Advancing Islet Transplants for the Treatment of Type I Diabetes Care
Protocols are currently being finalized. Trials will be multi-center involving both Islet after Kidney Transplantation and Islet Cell Transplant alone.
Learn more . . .